Transplantation and Cellular Therapy | 2025
Out-of-pocket expenditures and financial hardship among patients with myelodysplastic syndrome undergoing allogeneic transplant or hypomethylating agent / supportive care (BMT CTN 1102).
Su CT, Saber W, Bansal A, Li L, Nakamura R, Cutler C, Wright W, Steuten L, Roth JA, Ramsey SD
PubMed
PMID: 40320146
Abstract
Related Articles
CIBMTR Study #: 1102